Annual report pursuant to Section 13 and 15(d)

Schedule of Fair Value and Recognized Gain Loss on Deconsolidation of Subsidiary (Details)

v3.22.1
Schedule of Fair Value and Recognized Gain Loss on Deconsolidation of Subsidiary (Details) - USD ($)
12 Months Ended
Jul. 29, 2021
Dec. 31, 2021
Dec. 31, 2020
Accounting Policies [Abstract]      
Shares of common stock 119,584,736 - Descrypto    
Fair value of consideration received    
Cash 53,178    
Trademark 2,835    
Intangible assets – net 9,500    
Total assets assigned to Descrypto 65,513    
Accounts payable and accrued expenses 56,489    
Due to Balance Labs, Inc. 25,764    
Due to Lyons Capital, LLC 25,000    
Note payable 112,167    
Total liabilities assumed by Descrypto 219,420    
Total net liabilities assumed by Descrypto 153,907    
Gain on deconsolidation of KryptoBank $ 153,907 $ 153,907